Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI)

Neuroscience Letters

Volumn 409, Issue 1, 2006, Pages 65-69

  Yao, Xiang Lan ^a   Liu, Jiong ^a   Lee, Eleanor ^a   Ling, Geoffrey S F ^a   McCabe, Joseph T ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Cullin 5; E3 ligase; Gene expression; Proteasome; Protein degradation; Traumatic brain injury

Indexed keywords

MESSENGER RNA; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CULLIN 5 GENE; EUKARYOTIC CELL; GENE; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; CEREBRAL CORTEX; CULLIN PROTEINS; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASES;

EID: 33750060294     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.015     Document Type: Article

References (28)

1. Ayyub C., Sen A., Gonsalves F., Badrinath K., Bhandari P., Shashidhara L.S., Krishna S., and Rodrigues V. Cullin-5 plays multiple roles in cell fate specification and synapse formation during Drosophila development. Dev. Dyn. 232 (2005) 865-875
2. Brown M.B., and Forsythe A.B. Robust tests for equality of variances. J. Am. Stat. Assoc. 69 (1974) 364-367
3. Burnatowska-Hledin M., Zhao P., Capps B., Poel A., Parmelee K., Mungall C., Sharangpani A., and Listenberger L. VACM-1, a cullin gene family member, regulates cellular signaling. Am. J. Physiol. Cell Physiol. 279 (2000) C266-C273
4. Burnatowska-Hledin M.A., Kossoris J.B., Van Dort C.J., Shearer R.L., Zhao P., Murrey D.A., Abbott J.L., Kan C.E., and Barney C.C. T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene. Biochem. Biophys. Res. Commun. 319 (2004) 817-825
5. Burnatowska-Hledin M.A., Spielman W.S., Smith W.L., Shi P., Meyer J.M., and Dewitt D.L. Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla. Am. J. Physiol. 268 (1995) F1198-F1210
6. Byrd P.J., Stankovic T., McConville C.M., Smith A.D., Cooper P.R., and Taylor A.M. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res. 7 (1997) 71-75
7. Ceremuga T.E., Yao X.L., Alam H.B., and McCabe J.T. Alterations of cullin-5 mRNA levels in the rat central nervous system following hemorrhagic shock. Neurol. Res. 25 (2003) 211-216
8. Ceremuga T.E., Yao X.L., and McCabe J.T. Cullin-5 is ubiquitous in the rat brain. Neurosci. Lett. 345 (2003) 121-125
9. Ceremuga T.E., Yao X.L., and McCabe J.T. Vasopressin-activated calcium-mobilizing (VACM-1) receptor mRNA is present in peripheral organs and the central nervous system of the laboratory rat. Endocr. Res. 27 (2001) 433-445
10. Ceremuga T.E., Yao X.L., Xia Y., Mukherjee D., and McCabe J.T. Osmotic stress increases cullin-5 (cul-5) mRNA in the rat cerebral cortex, hypothalamus and kidney. Neurosci. Res. 45 (2003) 305-311
11. Deshaies R.J. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15 (1999) 435-467
12. Dias D.C., Dolios G., Wang R., and Pan Z.Q. CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc. Natl. Acad. Sci. USA 99 (2002) 16601-16606
13. Fay M.J., Longo K.A., Karathanasis G.A., Shope D.M., Mandernach C.J., Leong J.R., Hicks A., Pherson K., and Husain A. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol. Cancer 2 (2003) 40
14. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
15. Graham D.I., Adams J.H., Nicoll J.A., Maxwell W.L., and Gennarelli T.A. The nature, distribution and causes of traumatic brain injury. Brain Pathol. 5 (1995) 397-406
16. Hegde A.N. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 73 (2004) 311-357
17. Heuze M.L., Guibal F.C., Banks C.A., Conaway J.W., Conaway R.C., Cayre Y.E., Benecke A., and Lutz P.G. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex. J. Biol. Chem. 280 (2005) 5468-5474
18. Hurbin A., Orcel H., Ferraz C., Moos F.C., and Rabie A. Expression of the genes encoding the vasopressin-activated calcium-mobilizing receptor and the dual angiotensin II/vasopressin receptor in the rat central nervous system. J. Neuroendocrinol. 12 (2000) 677-684
19. Kamura T., Maenaka K., Kotoshiba S., Matsumoto M., Kohda D., Conaway R.C., Conaway J.W., and Nakayama K.I. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18 (2004) 3055-3065
20. Kipreos E.T., Lander L.E., Wing J.P., He W.W., and Hedgecock E.M. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 85 (1996) 829-839
21. Kohroki J., Nishiyama T., Nakamura T., and Masuho Y. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett. 579 (2005) 6796-6802
22. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503-533
23. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., and Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15 (2001) 3104-3117
24. Sartor A., Kossoris J.B., Wilcox R., Shearer R., Zeneberg A.E., Zhao P., Lazdins I., and Burnatowska-Hledin M.A. Truncated form of VACM-1/cul-5 with an extended 3′ untranslated region stimulates cell growth via a MAPK-dependent pathway. Biochem. Biophys. Res. Commun. 343 (2006) 1086-1093
25. Singhal S., Amin K.M., Kruklitis R., DeLong P., Friscia M.E., Litzky L.A., Putt M.E., Kaiser L.R., and Albelda S.M. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol. Ther. 2 (2003) 291-298
26. Van Dort C., Zhao P., Parmelee K., Capps B., Poel A., Listenberger L., Kossoris J., Wasilevich B., Murrey D., Clare P., and Burnatowska-Hledin M. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am. J. Physiol. Cell Physiol. 285 (2003) C1386-C1396
27. Yao X.L., Liu J., Lee E., Ling G.S.F., and McCabe J.T. Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury (TBI) in rats. J. Neurotrauma. 22 (2005) 656-668
28. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., and Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 (2003) 1056-1060